Teva Pharmaceutical agrees to opioid settlement, and forecasts return to growth

Teva Pharmaceutical (NYSE:TEVA) agreed to a settlement in a major lawsuit for its role in the opioid crisis — sending its stock up 28%. Opioids — used as painkillers — were initially prescribed in extreme cases, but over the past few decades, companies began pushing usage in more applications. Tsunami of lawsuits Big pharma made…

Read more